| Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey A Versporten, P Zarb, I Caniaux, MF Gros, N Drapier, M Miller, V Jarlier, ... The Lancet Global Health 6 (6), e619-e629, 2018 | 579 | 2018 |
| Genome-wide association analyses identifies a susceptibility locus for tuberculosis on chromosome 18q11. 2 T Thye, FO Vannberg, SH Wong, E Owusu-Dabo, I Osei, J Gyapong, ... Nature genetics 42 (9), 739-741, 2010 | 407 | 2010 |
| The Worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for … A Versporten, J Bielicki, N Drapier, M Sharland, H Goossens, ... Journal of Antimicrobial Chemotherapy 71 (4), 1106-1117, 2016 | 311 | 2016 |
| Use of the WHO Access, Watch, and Reserve classification to define patterns of hospital antibiotic use (AWaRe): an analysis of paediatric survey data from 56 countries Y Hsia, BR Lee, A Versporten, Y Yang, J Bielicki, C Jackson, J Newland, ... The Lancet Global Health 7 (7), e861-e871, 2019 | 268 | 2019 |
| Autophagy Gene Variant IRGM −261T Contributes to Protection from Tuberculosis Caused by Mycobacterium tuberculosis but Not by M. africanum Strains CD Intemann, T Thye, S Niemann, ENL Browne, M Amanua Chinbuah, ... PLoS pathogens 5 (9), e1000577, 2009 | 262 | 2009 |
| Reappraisal of known malaria resistance loci in a large multicenter study Nature genetics 46 (11), 1197-1204, 2014 | 237 | 2014 |
| Insights into malaria susceptibility using genome-wide data on 17,000 individuals from Africa, Asia and Oceania Nature communications 10 (1), 5732, 2019 | 132 | 2019 |
| Admixture into and within sub-Saharan Africa GBJ Busby, G Band, Q Si Le, M Jallow, E Bougama, VD Mangano, ... elife 5, e15266, 2016 | 131 | 2016 |
| Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study CM Ndila, S Uyoga, AW Macharia, G Nyutu, N Peshu, J Ojal, M Shebe, ... The Lancet Haematology 5 (8), e333-e345, 2018 | 106 | 2018 |
| Characterisation of the opposing effects of G6PD deficiency on cerebral malaria and severe malarial anaemia GM Clarke, K Rockett, K Kivinen, C Hubbart, AE Jeffreys, K Rowlands, ... elife 6, e15085, 2017 | 85 | 2017 |
| Variant G57E of mannose binding lectin associated with protection against tuberculosis caused by Mycobacterium africanum but not by M. tuberculosis T Thye, S Niemann, K Walter, S Homolka, CD Intemann, MA Chinbuah, ... PloS one 6 (6), e20908, 2011 | 85 | 2011 |
| Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): Results from a worldwide point prevalence … I Pauwels, A Versporten, N Drapier, E Vlieghe, H Goossens Journal of Antimicrobial Chemotherapy 76 (6), 1614-1624, 2021 | 81 | 2021 |
| Assessment of clinical outcomes among children and adolescents hospitalized with COVID-19 in 6 sub-Saharan African countries JB Nachega, NA Sam-Agudu, RN Machekano, H Rabie, MM van der Zalm, ... JAMA pediatrics 176 (3), e216436-e216436, 2022 | 61 | 2022 |
| Pharmacokinetics of first-line antituberculosis drugs using WHO revised dosage in children with tuberculosis with and without HIV coinfection A Kwara, A Enimil, FS Gillani, H Yang, AM Sarfo, A Dompreh, A Ortsin, ... Journal of the Pediatric Infectious Diseases Society 5 (4), 356-365, 2016 | 50 | 2016 |
| High rates of prescribing antimicrobials for prophylaxis in children and neonates: results from the antibiotic resistance and prescribing in European children point prevalence … M Hufnagel, A Versporten, J Bielicki, N Drapier, M Sharland, H Goossens Journal of the Pediatric Infectious Diseases Society 8 (2), 143-151, 2019 | 49 | 2019 |
| Mycobacterium tuberculosis drug resistance, Ghana E Owusu-Dabo, O Adjei, CG Meyer, RD Horstmann, A Enimil, TF Kruppa, ... Emerging infectious diseases 12 (7), 1170, 2006 | 47 | 2006 |
| Quality of life among Ghanaian adolescents living with perinatally acquired HIV: a mixed methods study A Enimil, N Nugent, C Amoah, B Norman, S Antwi, J Ocran, A Kwara, ... AIDS care 28 (4), 460-464, 2016 | 46 | 2016 |
| Pharmacokinetics of the first-line antituberculosis drugs in Ghanaian children with tuberculosis with or without HIV coinfection S Antwi, H Yang, A Enimil, AM Sarfo, FS Gillani, D Ansong, A Dompreh, ... Antimicrobial agents and chemotherapy 61 (2), 10.1128/aac. 01701-16, 2017 | 41 | 2017 |
| Evaluation of the adequacy of WHO revised dosages of the first-line antituberculosis drugs in children with tuberculosis using population pharmacokinetic modeling and simulations Y Horita, A Alsultan, A Kwara, S Antwi, A Enimil, A Ortsin, A Dompreh, ... Antimicrobial agents and chemotherapy 62 (9), 10.1128/aac. 00008-18, 2018 | 35 | 2018 |
| Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis A Dompreh, X Tang, J Zhou, H Yang, A Topletz, E Adu Ahwireng, S Antwi, ... Antimicrobial agents and chemotherapy 62 (3), 10.1128/aac. 02099-17, 2018 | 35 | 2018 |
